DK1114156T3 - Transformerende vækstfaktor Beta-9 (ZTGFSS9) fra pattedyr - Google Patents

Transformerende vækstfaktor Beta-9 (ZTGFSS9) fra pattedyr

Info

Publication number: DK1114156T3
Authority: DK; Denmark
Prior art keywords: seq; ztgfss9; mammals; growth factor; transforming growth
Prior art date: 1998-09-17

Application number

DK99969114T

Other languages

English (en)

Inventor

Scott R Presnell

David W Taft

Kevin P Foley

Original Assignee

Zymogenetics Inc

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1998-09-17

Filing date

1999-09-17

Publication date

2008-03-03

1999-09-17 Application filed by Zymogenetics Inc filed Critical Zymogenetics Inc

2008-03-03 Application granted granted Critical

2008-03-03 Publication of DK1114156T3 publication Critical patent/DK1114156T3/da

Links

241000124008 Mammalia Species 0.000 title 1
102000009618 Transforming Growth Factors Human genes 0.000 title 1
108010009583 Transforming Growth Factors Proteins 0.000 title 1
229920001184 polypeptide Polymers 0.000 abstract 3
102000004196 processed proteins & peptides Human genes 0.000 abstract 3
108090000765 processed proteins & peptides Proteins 0.000 abstract 3
125000003275 alpha amino acid group Chemical group 0.000 abstract 2
102000040430 polynucleotide Human genes 0.000 abstract 1
108091033319 polynucleotide Proteins 0.000 abstract 1
239000002157 polynucleotide Substances 0.000 abstract 1
230000001225 therapeutic effect Effects 0.000 abstract 1

Classifications

- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/475—Growth factors; Growth regulators
- C07K14/495—Transforming growth factor [TGF]
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P21/00—Drugs for disorders of the muscular or neuromuscular system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/02—Drugs for disorders of the nervous system for peripheral neuropathies
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
- A61P25/16—Anti-Parkinson drugs
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides

Landscapes

Health & Medical Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
Chemical & Material Sciences (AREA)
Organic Chemistry (AREA)
Neurology (AREA)
Bioinformatics & Cheminformatics (AREA)
Engineering & Computer Science (AREA)
General Health & Medical Sciences (AREA)
Medicinal Chemistry (AREA)
Biomedical Technology (AREA)
Neurosurgery (AREA)
Pharmacology & Pharmacy (AREA)
Animal Behavior & Ethology (AREA)
General Chemical & Material Sciences (AREA)
Public Health (AREA)
Veterinary Medicine (AREA)
Chemical Kinetics & Catalysis (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Orthopedic Medicine & Surgery (AREA)
Biochemistry (AREA)
Communicable Diseases (AREA)
Psychology (AREA)
Hospice & Palliative Care (AREA)
Psychiatry (AREA)
Oncology (AREA)
Physical Education & Sports Medicine (AREA)
Toxicology (AREA)
Zoology (AREA)
Gastroenterology & Hepatology (AREA)
Virology (AREA)
Biophysics (AREA)
Genetics & Genomics (AREA)
Molecular Biology (AREA)
Proteomics, Peptides & Aminoacids (AREA)
Peptides Or Proteins (AREA)
Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Micro-Organisms Or Cultivation Processes Thereof (AREA)
Preparation Of Compounds By Using Micro-Organisms (AREA)
Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)

DK99969114T 1998-09-17 1999-09-17 Transformerende vækstfaktor Beta-9 (ZTGFSS9) fra pattedyr DK1114156T3 (da)

Applications Claiming Priority (2)

Application Number	Priority Date	Filing Date	Title
US15481798A	1998-09-17	1998-09-17
PCT/US1999/021677 WO2000015798A2 (en)	1998-09-17	1999-09-17	Mammalian transforming growth factor beta - 9 (ztgfss9)

Publications (1)

Publication Number	Publication Date
DK1114156T3 true DK1114156T3 (da)	2008-03-03

Family

ID=22552920

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
DK99969114T DK1114156T3 (da)	1998-09-17	1999-09-17	Transformerende vækstfaktor Beta-9 (ZTGFSS9) fra pattedyr

Country Status (11)

Country	Link
EP (2)	EP1897948A1 (da)
JP (2)	JP2002525056A (da)
AT (1)	ATE378408T1 (da)
AU (1)	AU6050499A (da)
CA (2)	CA2706859A1 (da)
DE (1)	DE69937570T2 (da)
DK (1)	DK1114156T3 (da)
ES (1)	ES2300154T3 (da)
IL (1)	IL141869A0 (da)
WO (1)	WO2000015798A2 (da)
ZA (1)	ZA200101819B (da)

Families Citing this family (17)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US6562578B1 (en)	1999-01-11	2003-05-13	Schering Corporation	IL-17-like cytokine binding compounds and antibodies
US7771719B1 (en)	2000-01-11	2010-08-10	Genentech, Inc.	Pharmaceutical compositions, kits, and therapeutic uses of antagonist antibodies to IL-17E
NZ508878A (en)	1998-05-15	2003-08-29	Genentech Inc	IL-17B and IL-17Cactive variants of IL-17 which stimulates epithelial, endothelial and fibroblastic cells
EP1443055A3 (en) *	1998-05-29	2005-06-08	Human Genome Sciences, Inc.	Interleukins-21 and 22
DE60043051D1 (de) *	1999-01-11	2009-11-12	Schering Corp	Dafür kodierende polynukleotide. verwendungen
US20040043397A1 (en)	2000-01-11	2004-03-04	Genentech, Inc.	IL-17 homologous polypeptides and therapeutic uses thereof
DK1897944T3 (da) *	1999-12-23	2011-10-24	Genentech Inc	IL-17 homologe polypeptider og terapeutisk anvendelse deraf
US7718397B2 (en)	2000-03-21	2010-05-18	Genentech, Inc.	Nucleic acids encoding receptor for IL-17 homologous polypeptides and uses thereof
AU2001265157A1 (en) *	2000-05-31	2001-12-11	Zymogenetics Inc.	Mammalian transforming growth factor beta-10
US20030096969A1 (en)	2000-06-02	2003-05-22	Genentech, Inc.	Secreted and transmembrane polypeptides and nucleic acids encoding the same
US20020151695A1 (en) *	2000-11-28	2002-10-17	Shuqian Jing	Transforming growth factor-beta-related molecules and uses thereof
EP1359938B1 (en) *	2001-01-25	2011-03-16	ZymoGenetics, Inc.	Method for treating psoriasis by using an il-17d antagonist
US20040259779A1 (en) *	2001-07-06	2004-12-23	Teit Johansen	Novel neurotrophic factors
GB0417487D0 (en)	2004-08-05	2004-09-08	Novartis Ag	Organic compound
CA2669267A1 (en) *	2006-11-08	2008-05-15	Zymogenetics, Inc.	Methods of using transforming growth factor beata-9
SG10201608871XA (en)	2008-05-05	2016-12-29	Novimmune Sa	Anti-il-17a/il-17f cross-reactive antibodies and methods of use thereof
CA2759848C (en)	2009-05-05	2018-12-04	Novimmune S.A.	Anti-il-17f antibodies and methods of use thereof

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US5532159A (en) *	1994-04-01	1996-07-02	The Ohio State University	Monoclonal antibody to canine placental oncofetal protein for detecting cancer
EP0839196B1 (en) *	1995-07-19	2005-05-11	Genetics Institute, LLC	Human ctla-8 and uses of ctla-8-related proteins
EP0977861B1 (en) *	1997-04-25	2004-06-23	ZymoGenetics, Inc.	Mammalian cytokine-like factor 7
CA2329274A1 (en)	1998-05-29	1999-12-02	Steven M. Ruben	Interleukin-21
DE60043051D1 (de)	1999-01-11	2009-11-12	Schering Corp	Dafür kodierende polynukleotide. verwendungen

1999
- 1999-09-17 DK DK99969114T patent/DK1114156T3/da active
- 1999-09-17 AT AT99969114T patent/ATE378408T1/de active
- 1999-09-17 JP JP2000570325A patent/JP2002525056A/ja not_active Withdrawn
- 1999-09-17 WO PCT/US1999/021677 patent/WO2000015798A2/en not_active Ceased
- 1999-09-17 EP EP07017934A patent/EP1897948A1/en not_active Withdrawn
- 1999-09-17 ES ES99969114T patent/ES2300154T3/es not_active Expired - Lifetime
- 1999-09-17 AU AU60504/99A patent/AU6050499A/en not_active Abandoned
- 1999-09-17 CA CA2706859A patent/CA2706859A1/en not_active Abandoned
- 1999-09-17 CA CA2343569A patent/CA2343569C/en not_active Expired - Fee Related
- 1999-09-17 IL IL14186999A patent/IL141869A0/xx unknown
- 1999-09-17 EP EP99969114A patent/EP1114156B1/en not_active Expired - Lifetime
- 1999-09-17 DE DE69937570T patent/DE69937570T2/de not_active Expired - Lifetime
2001
- 2001-03-05 ZA ZA200101819A patent/ZA200101819B/en unknown
2010
- 2010-04-22 JP JP2010098890A patent/JP2010187691A/ja active Pending

Also Published As

Publication number	Publication date
AU6050499A (en)	2000-04-03
ATE378408T1 (de)	2007-11-15
JP2010187691A (ja)	2010-09-02
DE69937570T2 (de)	2009-04-23
EP1897948A1 (en)	2008-03-12
JP2002525056A (ja)	2002-08-13
EP1114156B1 (en)	2007-11-14
IL141869A0 (en)	2002-03-10
ES2300154T3 (es)	2008-06-01
WO2000015798A3 (en)	2000-05-25
CA2706859A1 (en)	2000-03-23
CA2343569C (en)	2010-09-14
CA2343569A1 (en)	2000-03-23
DE69937570D1 (de)	2007-12-27
EP1114156A2 (en)	2001-07-11
ZA200101819B (en)	2001-09-27
WO2000015798A2 (en)	2000-03-23

Publication	Publication Date	Title
DK1114156T3 (da)	2008-03-03	Transformerende vækstfaktor Beta-9 (ZTGFSS9) fra pattedyr
IL210454A0 (en)	2011-03-31	Novel cytokine zcytor17 ligand
DK0839196T3 (da)	2005-09-12	Humant CTLA-8 og anvendelser af CTLA-8-relaterede proteiner
DE69824755D1 (de)	2004-07-29	Cytokinähnliches polypeptid-10 aus säugetieren
DE60329070D1 (de)	2009-10-15	Antikörper gegen den fibroblastenwachstumsfaktor 23
MY123740A (en)	2006-06-30	Il-13 receptor polypeptide
IL212140A0 (en)	2011-06-30	Antibodies against acpl polypeptides
DE69936105D1 (de)	2007-06-28	Menschliche tslp nukleinsäuren und polypeptide
EP1037999A4 (en)	2005-03-23	POLYPEPTIDES AND NUCLEOTIDES PORPHYROMONAS GINGIVALIS
EA201001190A1 (ru)	2011-04-29	Выделенное антитело, специфически связанное с полипептидом, состоящее из последовательности аминокислотных остатков
EP0546087A4 (da)	1994-01-05
DE69929454D1 (de)	2006-04-06	Neue aminosäuresequenzen, deren kodierende dns, antikörper dagegen und deren verwendungen
DK0773999T3 (da)	2002-07-22	OR-1, en orphan-receptor tilhørende kernereceptorfamilien
EA200100440A1 (ru)	2001-10-22	Ген prv-1 и его применение
EP1295943A4 (en)	2005-11-16	POLYPEPTIDES CAPABLE THE POWER TO STIMULATE NEUTROPHILES
NZ606260A (en)	2014-10-31	Novel polypeptides involved in immune response